Table 5 Factors associated with HBV screening during one’s lifetime and anti-HBV vaccination, KABP survey, France, 2010 (multivariate analysis)
HBV screening | Anti-HBV vaccination | |||||
|---|---|---|---|---|---|---|
% | Adjusted OR | CI 95% | % | Adjusted OR | CI 95% | |
Gender | ||||||
Men | 27.1 | 1 | 45.1 | 1 | ||
Women | 27.8 | 0.95 | 0.9-1.1 | 48.9 | 1.2 | 1.1-1.3 |
Age (in years) | ||||||
18–30 | 26.0 | 1 | 62.3 | 1 | ||
31–44 | 32.6 | 1.3 | 1.2-1.5 | 54.5 | 0.7 | 0.6-0.7 |
45–54 | 26.5 | 1.2 | 0.97-1.4 | 36.4 | 0.3 | 0.3-0.4 |
55-69 | 21.7 | 1.1 | 0.9-1.3 | 27.4 | 0.2 | 0.2-0.3 |
Educational level | ||||||
No educational qualification | 18.2 | 1 | 33.7 | 1 | ||
CAP/BEP/BEPC (vocational diplomas) | 23.4 | 1.4 | 1.04-1.6 | 41.3 | 1.1 | 0.9-1.3 |
Secondary school certificate | 26.1 | 1.5 | 1.1-1.8 | 49.5 | 1.2 | 1.01-1.5 |
Higher education qualification | 34.2 | 1.8 | 1.5-2.3 | 54.4 | 1.5 | 1.2-1.8 |
Net monthly income per household | ||||||
<2,000 € | 25.6 | 1 | 45.8 | 1 | ||
2,000–2,999 € | 26.6 | 0.9 | 0.8-1.1 | 47.4 | 1.0 | 0.9-1.2 |
≥ 3,000 € | 30.4 | 0.9 | 0.8-1.1 | 48.2 | 1.0 | 0.9-1.2 |
Did not wish to share this information/ Did not know | 16.2 | 0.6 | 0.4-0.9 | 40.5 | 0.9 | 0.6-1.3 |
Area of residence | ||||||
Outside the Ile-de-France administrative district | 26.2 | 1 | 46.1 | 1 | ||
Ile-de-France administrative district (which includes Paris) | 32.5 | 1.2 | 1.04-1.3 | 50.9 | 1.0 | 0.9-1.2 |
Living in a couple or a stable relationship | ||||||
No | 25.4 | 1 | 48.0 | 1 | ||
Yes | 28.1 | 1.1 | 0.98-1.3 | 46.8 | 1.0 | 0.9-1.2 |
Knowing someone in circle of family and friends who was infected | ||||||
No | 23.7 | 1 | 46.5 | 1 | ||
Yes | 41.1 | 2.1 | 1.9-2.4 | 49.0 | 1.0 | 0.9-1.2 |
Having a good level of knowledge about HBV transmission modes | ||||||
No | 23.9 | 1 | 44.3 | 1 | ||
Yes | 33.6 | 1.4 | 1.3-1.6 | 51.7 | 1.1 | 0.97-1.2 |
Perception of being at greater risk of HBV infection with respect to the average person | ||||||
No | 25.6 | 1 | 45.5 | 1 | ||
Yes | 50.1 | 2.5 | 2.1-3.1 | 66.1 | 2.2 | 1.8-2.7 |
HBV endemicity in country of birth1 | ||||||
Low | 26.8 | 1 | 46.8 | 1 | ||
Intermediate | 30.1 | 1.2 | 0.9-1.4 | 47.3 | 1.1 | 0.9-1.4 |
High | 45.1 | 2.1 | 1.5-2.9 | 56.1 | 1.2 | 0.8-1.6 |
Intravenous drug use in one’s lifetime | ||||||
No | 27.4 | 1 | 47.0 | 1 | ||
Yes | 45.6 | 2.2 | 1.2-4.2 | 52.1 | 1.2 | 0.6-2.4 |
HBV screening during one’s lifetime | ||||||
No | - | - | - | 40.3 | 1 | |
Yes | 64.8 | 2.4 | 2.2-2.7 | |||
Anti-HBV vaccination | ||||||
No | 18.3 | 1 | - | - | - | |
Yes | 37.8 | 2.4 | 2.2-2.7 | |||